L-asparaginases have attracted a significant amount of attention owing to their clinical use in acute lymphoblastic leukemia treatment and their range of applications in the food industry in order to reduce acrylamide formation in fried and baked foods, especially in potato chips, coffee, and cookies [36,37]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.